Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05175456 · ClinicalTrials.gov registry record · NA

Use of a Sleep System to Improve Sleep

A NA study, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
NA
Development phase
59
Enrollment target

NCT05175456: Completed NA study, sponsored by University of Massachusetts, Worcester.

NCT05175456 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 59 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05175456, a NA study, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
NA
Development phase
59 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effect of a bed cooling system on subjective and objective measures of sleep in physicians who work rotating shifts. The intent of the Investigators is to perform a before-and-after trial of a bed cooling system and determine the effects of that cooling system on sleep.

Primary Outcome

change in average SQS from before and after time periods Sleep quality information will be evaluated using the Sleep Quality Scale (SQS), an \[# of questions\] survey that asks questions to obtain information regarding quality of sleep. The range of scores on the survey is \[X\] to \[X\], with \[X\] indicating poor sleep quality and (X\] indicating good sleep quality. The outcome will reflect the change in score values from baseline (4 weeks) to post-use of BedJet (4 weeks)

Interventions

  • DEVICE FitBit
  • OTHER Bedjet

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2021-11-30
Est. Completion 2022-02-05
Phase NA

What the finished NCT05175456 record still lists

NCT05175456 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which FitBit is the first listed.

NCT05175456 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05175456 about?

NCT05175456 is a clinical study titled "Use of a Sleep System to Improve Sleep". The purpose of this study is to determine the effect of a bed cooling system on subjective and objective measures of sleep in physicians who work rotating shifts. The intent of the Investigators is to perform a before-and-after trial of a bed cooling system and determine the effects of that cooling ...

What is the current status of trial NCT05175456?

This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2021-11-30. Estimated completion is 2022-02-05.

What interventions are being tested in trial NCT05175456?

The interventions under investigation include: FitBit (DEVICE), Bedjet (OTHER).

Who is sponsoring clinical trial NCT05175456?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05175456's enrollment target sits among peer trials

59 1256th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03801083 · 59 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

  • NCT04332367 · 59 participants · Phase 2

    Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance

  • NCT05489575 · 59 participants · NA

    CPAP for the Treatment of Supine Hypertension

  • NCT06721689 · 59 participants · Phase 1

    PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05175456, the US trial registry maintained by the National Library of Medicine. NCT05175456 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.